Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

New technology, which hundred of thousands of women will be invited to help test over the coming months, could improve ...

Novartis’ Kisqali (ribociclib) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat a ...

Nearly 700,000 women across the UK will take part in an NHS Artificial Intelligence (AI) trial designed to detect breast ...

Novartis UK announced the Medicines and Healthcare products Regulatory Agency (MHRA) has authorised ribociclib for adjuvant ...

Nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social ...

In December 2022, at the age of 33, Emily began suffering from severe bloating that made her appear "seven months pregnant".

Then 33, Emily started experiencing some severe bloating to the extent that it made her look “seven months pregnant”. Less ...

Nearly 700,000 UK women are participating in an NHS trial to use AI for early detection of breast cancer. The trial aims to improve screening accuracy and efficiency, potentially freeing up medical ...

The NHS is launching the world's largest artificial intelligence trial for breast cancer detection - which is set to analyse ...

The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five ...